Bionorica SE
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 1933-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.bionorica.de
Clinical Trials
28
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (21 trials with phase data)• Click on a phase to view related trials
Efficacy of Vitex Agnus-castus BNO 1095 (20 mg) in Women With Primary Dysmenorrhea
- Conditions
- Primary Dysmenorrhea
- Interventions
- Drug: PlaceboDrug: Vitex agnus-castus BNO 1095 (20 mg)
- First Posted Date
- 2024-01-18
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Bionorica SE
- Target Recruit Count
- 286
- Registration Number
- NCT06211049
- Locations
- 🇦🇹
Medizinische Universität Innsbruck, Department Frauenheilkunde, Universitätsklinik für Gynäkologische Endokrinologie und Reproduktionsmedizin, Innsbruck, Austria
🇦🇹Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin, Wien, Austria
🇨🇿Centrum ambulantní gynekologie a primární péče s.r.o., Brno Střed, Czechia
Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 5 Days of Use on Subjects With Atopic Dermatitis
- Conditions
- Atopic DiathesisEczema-prone Skin
- First Posted Date
- 2023-04-11
- Last Posted Date
- 2023-04-11
- Lead Sponsor
- Bionorica SE
- Target Recruit Count
- 44
- Registration Number
- NCT05807113
- Locations
- 🇩🇪
SGS proderm GmbH, Schenefeld, Germany
Skin Efficacy and Tolerability of a Cosmetic Product Combination Over 3 Months in Subjects With Atopic Eczema
- Conditions
- Atopic DermatitisEczema-Prone Skin
- First Posted Date
- 2023-03-29
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- Bionorica SE
- Target Recruit Count
- 100
- Registration Number
- NCT05790083
- Locations
- 🇩🇪
SGS proderm GmbH, Schenefeld, Germany
Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 4 Weeks of Use on Subjects With Atopic Dermatitis
- Conditions
- Atopic DiathesisEczema-Prone Skin
- First Posted Date
- 2023-03-28
- Last Posted Date
- 2023-03-28
- Lead Sponsor
- Bionorica SE
- Target Recruit Count
- 44
- Registration Number
- NCT05786976
- Locations
- 🇩🇪
SGS proderm GmbH, Schenefeld, Germany
BX-1 in Spasticity Due to Multiple Sclerosis
- First Posted Date
- 2018-11-28
- Last Posted Date
- 2021-05-05
- Lead Sponsor
- Bionorica SE
- Target Recruit Count
- 397
- Registration Number
- NCT03756974
- Locations
- 🇪🇸
Investigative Site, Valencia, Spain
🇨🇿Investigative site, Hradec Králové, Czechia
- Prev
- 1
- 2
- 3
- Next